January 2014 - Volume 24 - Issue 1
pp: 1-79

Confirmation of −174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome

Dávila-Fajardo, Cristina L.; Márquez, Ana; Pascual-Salcedo, Dora; More

Pharmacogenetics and Genomics. 24(1):1-5, January 2014.

The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study

de Keyser, Catherine E.; Peters, Bas J.M.; Becker, Matthijs L.; More

Pharmacogenetics and Genomics. 24(1):43-51, January 2014.